Trial
NCT03342352
Nivolumab Plus Epacadostat in Combination With Chemotherapy Versus the EXTREME Regimen in Squamous Cell Carcinoma of the Head and Neck (CheckMate 9NA/ECHO-310)
Phase IIIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Incyte Corporation
Collaborators
Bristol-Myers Squibb
Condition
Head and Neck Cancer
Intervention
Nivolumab
Why stopped
Study was cancelled prior to enrolling any patients.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-12-20